CommentPPAR agonists for primary biliary cholangitis
References (12)
- et al.
The X chromosome and immune associated genes
J Autoimmun
(2012) - et al.
Ursodeoxycholic acid for primary biliary cirrhosis
Lancet
(2000) - et al.
The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis
Gastroenterology
(2005) - et al.
Hepatotoxicity of the thiazolidinediones
Clin Liver Dis
(2003) - et al.
Fenofibrate is effective adjunctive therapy in the treatment of primary biliary cirrhosis: a meta-analysis
Clin Res Hepatol Gastroenterol
(2015) - et al.
A 2-year multicenter, double-blind, randomized, placebo-controlled study of bezafibrate for the treatment of primary biliary cholangitis in patients with inadequate biochemical response to ursodeoxycholic acid therapy (Bezurso)
J Hepatol
(2017)
There are more references available in the full text version of this article.
Cited by (0)
© 2017 Elsevier Ltd. All rights reserved.